Advertisement

Topics

Generic Sponsors Need To Increase Communications About Drug Master Files, US FDA Says

17:33 EDT 24 Aug 2017 | SCRIP

Industry complaining about issues in DMF completeness assessments, but few sponsors schedule teleconferences after complete response letters, FDA says.

      

Related Stories

 

Original Article: Generic Sponsors Need To Increase Communications About Drug Master Files, US FDA Says

NEXT ARTICLE

More From BioPortfolio on "Generic Sponsors Need To Increase Communications About Drug Master Files, US FDA Says"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...